Global Neurosyphilis Market Growth (Status and Outlook) 2023-2029

Global Neurosyphilis Market Growth (Status and Outlook) 2023-2029

Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%–40% of those who are not treated. The United States' Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection.

LPI (LP Information)' newest research report, the “Neurosyphilis Industry Forecast” looks at past sales and reviews total world Neurosyphilis sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurosyphilis sales for 2023 through 2029. With Neurosyphilis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurosyphilis industry.

This Insight Report provides a comprehensive analysis of the global Neurosyphilis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurosyphilis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurosyphilis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurosyphilis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurosyphilis.

The global Neurosyphilis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer's disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurosyphilis market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Asymptomatic Neurosyphilis
Meningeal Neurosyphilis
Meningovascular Neurosyphilis
Others

Segmentation by application
Hospital & Clinics
Medical Research Centers
Academic Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Bayer
Eli Lilly and Company
GlaxoSmithKline
Novartis
Pfizer
Sanofi

Please note: The report will take approximately 2 business days to prepare and deliver.